An Open-label, Single-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of Overnight Closed-loop Insulin Delivery Using Diluted Insulin in Comparison With Closed-loop With Non-diluted Insulin in Children With Type 1 Diabetes Aged 2 to 6 Years
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 12 Dec 2013 Accrual to date is 125% according to United Kingdom Clinical Research Network record.
- 12 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 07 Nov 2013 Accrual to date is 128% according to United Kingdom Clinical Research Network record.